Wed, May 29, 2024
The shares were disposed of at an average price of Rs 1,361.26 apiece, taking the deal value to Rs 483 crore.
More >
Fri, Aug 18, 2023
Concord Biotech, a biopharmaceuticals company, makes a remarkable entry in the stock market with a premium listing. Zee Business's Anil Singhvi shares valuable insights for both long-term and short-term investors. Find out the target price and strategies for holding on to Concord Biotech shares in this market update.
Ahmedabad-based Concord Biotech, an R&D-driven biopharma company, made a strong debut in the secondary market on August 18, listing at a premium of 21.5 per cent over the upper end of its IPO price band.
Wed, Aug 09, 2023
The basis of the allotment of shares under the Concord Biotech Limited IPO is likely to be finalised on August 11.
Fri, Aug 04, 2023
The Initial Public Offering (IPO) got bids for 85,05,660 shares against 1,46,50,957 on offer, according to the National Stock Exchange (NSE) data.
Mon, Jul 31, 2023
Concord Biotech IPO, Concord Biotech IPO price band: Rare Enterprises-backed Concord Biotech on Monday said it has fixed a price band of Rs 705-741 a share for its Rs 1,550 crore initial public offering (IPO). The initial share sale will be open for public subscription during August 4-8, the Ahmedabad-based company announced.
Tue, Aug 16, 2022
Concord Biotech IPO: The IPO is entirely an offer for sale of (OFS) of 2,09,25,652 equity shares by Helix Investment Holdings Pte Limited, which is backed by private equity firm Quadria Capital, according to the draft red herring prospectus (DRHP)
By accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.
